Street Reports

Analysts Review On Pfizer Inc. (NYSE:PFE)

Low Mortgage

The shares of Pfizer Inc. (NYSE:PFE)currently has mean rating of 2.2 while 10 analyst have recommended the shares as ‘BUY’ ,4 recommended as ‘OUTPERFORM’ and 9 recommended as ‘HOLD’.The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell

The mean price target for the shares of Pfizer Inc. (NYSE:PFE)is at $38.62 while the highest price target suggested by the analysts is $54.00 and low price target is $33.00. The mean price target is calculated keeping in view the consensus of 21 brokerage firms.

The company’s mean estimate for sales for the current quarter ending Jun 16 is 12.94B by 12 analysts. The means estimate of sales for the year ending Dec 16 is 52.40B by 18 analysts.

The average estimate of EPS for the current fiscal quarter for Pfizer Inc. (NYSE:PFE)stands at $0.62 while the EPS for the current year is fixed at $2.44 by 15.00 analysts

The next one year’s EPS estimate is set at 2.62 by 21.00 analysts while a year ago the analysts suggested the company’s EPS at $2.44. The analysts also projected the company’s long-term growth at 7.82% for the upcoming five years

In its latest quarter ended on 31 Mar 2016 , Pfizer Inc. (NYSE:PFE)reported earnings of $0.67. The posted earnings topped the analyst’s consensus by $0.12 with the surprise factor of 21.80%. In the matter of earnings surprises, the term ‘Cockroach Effect’ is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Pfizer Inc. (NYSE:PFE) traded up +0.35% during trading on Friday, hitting $34.74 . The stock had a trading volume of 23.7 M shares. The firm has a 50 day moving average of $34.21 and a 200-day moving average of $31.87. The stock has a market cap of $209.78B and a price-to-earnings ratio of 28.35. On Jul 31, 2015 the shares registered one year high at $36.46 and the one year low was seen on Feb 8, 2016.

On June 23, 2016 Pfizer Inc. (NYSE:PFE) declared a 30-cent third-quarter 2016 dividend on the company’s common stock, payable September 1, 2016, to shareholders of record at the close of business on August 5, 2016. The third-quarter 2016 cash dividend will be the 311th consecutive quarterly dividend paid by Pfizer.

Pfizer Inc.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. For more information, please visit us at www.pfizer.com. In addition, to learn more, follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Previous ArticleNext Article

Leave a Reply

Your email address will not be published. Required fields are marked *